Vir Biotechnology, Inc. Common Stock VIR
i
Market dataready · fetched 2026-11-04T02:45:00.214Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T23:36:02.62738529Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-04T02:44:59.799639+00:00
Vir Biotechnology, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 10.23 | 105.7% | 13.9% | |||
| 35Δ | 13.09 | 131.2% | 22.0% | 10.58 | 96.0% | 11.4% |
| 40Δ | 12.45 | 115.8% | 16.7% | 10.93 | 86.2% | 8.8% |
| 45Δ | 11.91 | 103.6% | 12.5% | 11.25 | 88.4% | 7.7% |
| 50Δ | 11.58 | 99.4% | 10.4% | 11.56 | 93.3% | 6.9% |
| 55Δ | 11.26 | 95.2% | 8.4% | 11.87 | 98.2% | 6.2% |
| 60Δ | 10.94 | 91.8% | 6.6% | 12.43 | 114.2% | 5.9% |
| 65Δ | 10.65 | 91.8% | 5.5% | 13.08 | 130.6% | 5.6% |
| 70Δ | 10.35 | 91.7% | 4.5% | 13.41 | 122.8% | 4.4% |
| 75Δ | 10.06 | 91.6% | 3.5% | 13.74 | 115.0% | 3.2% |
| 80Δ | 9.45 | 104.7% | 2.8% | 14.54 | 120.7% | 2.3% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.23
- IV
- 105.7%
- B/E move
- 13.9%
35Δ
- Pseudo strike
- 13.09
- IV
- 131.2%
- B/E move
- 22.0%
- Pseudo strike
- 10.58
- IV
- 96.0%
- B/E move
- 11.4%
40Δ
- Pseudo strike
- 12.45
- IV
- 115.8%
- B/E move
- 16.7%
- Pseudo strike
- 10.93
- IV
- 86.2%
- B/E move
- 8.8%
45Δ
- Pseudo strike
- 11.91
- IV
- 103.6%
- B/E move
- 12.5%
- Pseudo strike
- 11.25
- IV
- 88.4%
- B/E move
- 7.7%
50Δ
- Pseudo strike
- 11.58
- IV
- 99.4%
- B/E move
- 10.4%
- Pseudo strike
- 11.56
- IV
- 93.3%
- B/E move
- 6.9%
55Δ
- Pseudo strike
- 11.26
- IV
- 95.2%
- B/E move
- 8.4%
- Pseudo strike
- 11.87
- IV
- 98.2%
- B/E move
- 6.2%
60Δ
- Pseudo strike
- 10.94
- IV
- 91.8%
- B/E move
- 6.6%
- Pseudo strike
- 12.43
- IV
- 114.2%
- B/E move
- 5.9%
65Δ
- Pseudo strike
- 10.65
- IV
- 91.8%
- B/E move
- 5.5%
- Pseudo strike
- 13.08
- IV
- 130.6%
- B/E move
- 5.6%
70Δ
- Pseudo strike
- 10.35
- IV
- 91.7%
- B/E move
- 4.5%
- Pseudo strike
- 13.41
- IV
- 122.8%
- B/E move
- 4.4%
75Δ
- Pseudo strike
- 10.06
- IV
- 91.6%
- B/E move
- 3.5%
- Pseudo strike
- 13.74
- IV
- 115.0%
- B/E move
- 3.2%
80Δ
- Pseudo strike
- 9.45
- IV
- 104.7%
- B/E move
- 2.8%
- Pseudo strike
- 14.54
- IV
- 120.7%
- B/E move
- 2.3%
Options history
Table
| Date | IV (%) |
|---|---|
| 105.32% | |
| 90.73% | |
| 79.44% | |
| 88.73% | |
| 93.19% | |
| 97.11% | |
| 97.65% | |
| 86.38% | |
| 76.45% | |
| 85.97% |
Biotechnology
VKTX
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered…
More →VNDA
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is…
More →VOR
Description unavailable
More →VRDN
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. The company is headquartered in Boulder, Colorado.
More →VRTX
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
More →VSTM
Description unavailable
More →